AML and MDS associated with PARP inhibitor treatment of ovarian cancer

ElsevierVolume 171, April 2023, Pages 162-163Gynecologic OncologyAuthor links open overlay panelDeborah K. ArmstrongShow morePrevious article in issueNext article in issue

Recommended articles

View full text

© 2022 Elsevier Inc. All rights reserved.

Recommended articlesArticle Metrics

留言 (0)

沒有登入
gif